Are patients with hepatocellular carcinoma and portal vein tumour thrombosis candidates for liver transplantation?
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Are patients with hepatocellular carcinoma and portal vein tumour thrombosis candidates for liver transplantation?
Authors
Keywords
-
Journal
JOURNAL OF HEPATOLOGY
Volume 78, Issue 6, Pages 1124-1129
Publisher
Elsevier BV
Online
2023-05-18
DOI
10.1016/j.jhep.2023.03.032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging immunotherapy for HCC: A guide for hepatologists
- (2022) Friedrich Foerster et al. HEPATOLOGY
- Immune Checkpoint Inhibitor Use in Solid Organ Transplant Recipients: A Systematic Review
- (2022) Andrew J. Portuguese et al. Journal of the National Comprehensive Cancer Network
- Stereotactic body radiotherapy plus transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma patients with portal vein tumour thrombus: A meta-analysis
- (2022) Xiao-fei Zhang et al. PLoS One
- Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?
- (2022) Stéphanie Gonvers et al. Frontiers in Oncology
- Hepatocellular carcinoma
- (2022) Arndt Vogel et al. LANCET
- Clinical analysis of deceased donor liver transplantation in the treatment of hepatocellular carcinoma with segmental portal vein tumor thrombus: A long-term real-world study
- (2022) Meng Sha et al. Frontiers in Oncology
- Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
- (2021) A. Vogel et al. ANNALS OF ONCOLOGY
- Hepatocellular cancer selection systems and liver transplantation: from the tower of babel to an ideal comprehensive score
- (2021) Jan Lerut et al. Updates in Surgery
- Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first‐line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study
- (2021) Xiaoyan Ding et al. CANCER
- Long-term outcomes of deceased donor liver transplantation in hepatocellular carcinoma patients with portal vein tumor thrombus: A multicenter study
- (2021) Jiongjie Yu et al. EJSO
- Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasion
- (2021) Abu Bakar Hafeez Bhatti et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Deceased Donor Liver Transplantation After Radioembolization for Hepatocellular Carcinoma and Portal Vein Tumoral Thrombosis: A Pilot Study
- (2021) Matteo Serenari et al. LIVER TRANSPLANTATION
- Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma – The Changing Tides
- (2021) Abdul Rehman Khan et al. Journal of Hepatocellular Carcinoma
- Proton beam therapy to bridge or downstage locally advanced hepatocellular carcinoma to living donor liver transplantation
- (2021) Chao-Long Chen et al. Hepatobiliary Surgery and Nutrition
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: A systematic review
- (2020) Thibaut d’Izarny‐Gargas et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion – a multi‐center retrospective cohort study
- (2020) Michela Assalino et al. TRANSPLANT INTERNATIONAL
- Experience With LDLT in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Postdownstaging
- (2020) A.S. Soin et al. TRANSPLANTATION
- Liver Transplantation Following Yttrium‐90 Radioembolization: 15‐year Experience in 207‐Patient Cohort
- (2020) Ahmed Gabr et al. HEPATOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of stereotactic body radiotherapy for portal vein tumor thrombosis in patients with hepatocellular carcinoma and underlying chronic liver disease
- (2020) Hoon Sik Choi et al. Asia-Pacific Journal of Clinical Oncology
- Liquid biopsy in the clinical management of hepatocellular carcinoma
- (2020) Johann von Felden et al. GUT
- National Experience on Down‐staging of Hepatocellular Carcinoma before Liver Transplant: Influence of Tumor Burden, AFP , and Wait Time
- (2019) Neil Mehta et al. HEPATOLOGY
- Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
- (2019) Jens Ricke et al. JOURNAL OF HEPATOLOGY
- Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion
- (2018) Carlo Spreafico et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria)
- (2018) Josep M. Llovet et al. LIVER TRANSPLANTATION
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- 90Y Radioembolization for Locally Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Long-Term Outcomes in a 185-Patient Cohort
- (2017) Nadine Abouchaleh et al. JOURNAL OF NUCLEAR MEDICINE
- Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
- (2017) Valérie Vilgrain et al. LANCET ONCOLOGY
- The clinical outcomes of patients with portal vein tumor thrombi after living donor liver transplantation
- (2017) Ho Joong Choi et al. LIVER TRANSPLANTATION
- Management of Hepatocellular Carcinoma in Japan as a World-Leading Model
- (2017) Masatoshi Kudo Liver Cancer
- Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
- (2016) Jordi Bruix et al. GASTROENTEROLOGY
- Liver Transplantation After Transarterial Chemoembolization and Radiotherapy for Hepatocellular Carcinoma with Vascular Invasion
- (2016) Yuri Jeong et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Macrovascular invasion is not an absolute contraindication for living donor liver transplantation
- (2016) Kwang-Woong Lee et al. LIVER TRANSPLANTATION
- Vascular Invasion in Hepatocellular Carcinoma
- (2013) Yun-Hsuan Lee et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Effectiveness of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma with Portal Vein and/or Inferior Vena Cava Tumor Thrombosis
- (2013) Mian Xi et al. PLoS One
- Transplant benefit for patients with hepatocellular carcinoma
- (2013) Alessandro Vitale WORLD JOURNAL OF GASTROENTEROLOGY
- Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study
- (2011) Alessandro Vitale et al. LANCET ONCOLOGY
- Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
- (2011) Pierre-Alain Clavien et al. LANCET ONCOLOGY
- Surgical Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
- (2010) Jie Shi et al. ANNALS OF SURGICAL ONCOLOGY
- A new classification for hepatocellular carcinoma with portal vein tumor thrombus
- (2010) Jie Shi et al. Journal of Hepato-Biliary-Pancreatic Sciences
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now